|
1
|
The plasma lipidomic signature of nonalcoholic steatohepatitis.
|
Hepatology
|
2009
|
3.48
|
|
2
|
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
|
N Engl J Med
|
2010
|
2.97
|
|
3
|
Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
|
Gastroenterology
|
2013
|
2.82
|
|
4
|
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
|
Lancet
|
2012
|
2.43
|
|
5
|
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.
|
Am J Gastroenterol
|
2011
|
2.37
|
|
6
|
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.
|
Cell Metab
|
2012
|
1.97
|
|
7
|
The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
|
Hepatology
|
2013
|
1.92
|
|
8
|
Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography.
|
J Hepatol
|
2011
|
1.85
|
|
9
|
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
|
J Clin Oncol
|
2011
|
1.84
|
|
10
|
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.
|
J Clin Oncol
|
2012
|
1.75
|
|
11
|
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
|
J Hepatol
|
2013
|
1.66
|
|
12
|
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.
|
Gastroenterology
|
2010
|
1.58
|
|
13
|
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
|
PLoS One
|
2013
|
1.51
|
|
14
|
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
|
J Clin Oncol
|
2013
|
1.44
|
|
15
|
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
|
Blood
|
2008
|
1.20
|
|
16
|
Limit theorems for patterns in phylogenetic trees.
|
J Math Biol
|
2009
|
1.16
|
|
17
|
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
|
Blood
|
2014
|
1.11
|
|
18
|
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
|
J Clin Oncol
|
2012
|
1.09
|
|
19
|
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.
|
Blood
|
2011
|
1.08
|
|
20
|
Redox self-sufficient biocatalyst network for the amination of primary alcohols.
|
Angew Chem Int Ed Engl
|
2012
|
0.99
|
|
21
|
Legal and ethical consequences of international biobanking from a national perspective: the German BMB-EUCoop project.
|
Eur J Hum Genet
|
2009
|
0.98
|
|
22
|
Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.
|
Hepatology
|
2008
|
0.92
|
|
23
|
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.
|
J Clin Oncol
|
2013
|
0.92
|
|
24
|
Driving simulation can improve insight into impaired driving skills in cirrhosis.
|
Dig Dis Sci
|
2011
|
0.92
|
|
25
|
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
|
J Hepatol
|
2013
|
0.92
|
|
26
|
Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study.
|
Liver Transpl
|
2012
|
0.90
|
|
27
|
Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples.
|
Clin Gastroenterol Hepatol
|
2010
|
0.90
|
|
28
|
The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
|
Clin Liver Dis
|
2012
|
0.90
|
|
29
|
The LIFE child study: a life course approach to disease and health.
|
BMC Public Health
|
2012
|
0.88
|
|
30
|
CNS involvement in Hodgkin's lymphoma.
|
J Clin Oncol
|
2007
|
0.87
|
|
31
|
Clinical results of absorbable plates for displaced metacarpal fractures.
|
J Hand Surg Am
|
2007
|
0.87
|
|
32
|
A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
|
Clin Gastroenterol Hepatol
|
2008
|
0.87
|
|
33
|
Social withdrawal after laryngectomy.
|
Eur Arch Otorhinolaryngol
|
2009
|
0.87
|
|
34
|
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.
|
J Clin Oncol
|
2010
|
0.86
|
|
35
|
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment.
|
Antivir Ther
|
2009
|
0.86
|
|
36
|
Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study group.
|
J Clin Oncol
|
2009
|
0.86
|
|
37
|
The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphoma.
|
Int J Cancer
|
2007
|
0.86
|
|
38
|
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.
|
J Hepatol
|
2012
|
0.85
|
|
39
|
Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.
|
Metab Brain Dis
|
2014
|
0.85
|
|
40
|
Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
|
J Clin Oncol
|
2013
|
0.84
|
|
41
|
Herpes simplex virus colitis in a patient with Crohn's disease and hepatitis B and d cirrhosis.
|
Gastroenterol Hepatol (N Y)
|
2010
|
0.84
|
|
42
|
Hodgkin's lymphoma: current treatment strategies and novel approaches.
|
Expert Rev Hematol
|
2008
|
0.83
|
|
43
|
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
|
Blood
|
2011
|
0.83
|
|
44
|
Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant.
|
Leuk Lymphoma
|
2014
|
0.83
|
|
45
|
Microwave-assisted cross-coupling and hydrogenation chemistry by using heterogeneous transition-metal catalysts: an evaluation of the role of selective catalyst heating.
|
Chemistry
|
2009
|
0.82
|
|
46
|
Introducing an in situ capping strategy in systems biocatalysis to access 6-aminohexanoic acid.
|
Angew Chem Int Ed Engl
|
2014
|
0.82
|
|
47
|
A comparative analysis of biomedical research ethics regulation systems in Europe and Latin America with regard to the protection of human subjects.
|
J Med Ethics
|
2010
|
0.81
|
|
48
|
Artificial multi-enzyme networks for the asymmetric amination of sec-alcohols.
|
Chemistry
|
2013
|
0.81
|
|
49
|
The substrate tolerance of alcohol oxidases.
|
Appl Microbiol Biotechnol
|
2015
|
0.81
|
|
50
|
Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.
|
Biochem J
|
2002
|
0.81
|
|
51
|
One-pot deracemization of sec-alcohols: enantioconvergent enzymatic hydrolysis of alkyl sulfates using stereocomplementary sulfatases.
|
Angew Chem Int Ed Engl
|
2013
|
0.81
|
|
52
|
Migration pattern of a femoral short-stem prosthesis: a 2-year EBRA-FCA-study.
|
Arch Orthop Trauma Surg
|
2014
|
0.81
|
|
53
|
Safety and tolerability of agomelatine: focus on hepatotoxicity.
|
Curr Drug Metab
|
2014
|
0.80
|
|
54
|
Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation.
|
Am J Gastroenterol
|
2007
|
0.79
|
|
55
|
Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy.
|
Nutrition
|
2004
|
0.78
|
|
56
|
Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.
|
Biochim Biophys Acta
|
2004
|
0.78
|
|
57
|
Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma.
|
Leuk Lymphoma
|
2010
|
0.77
|
|
58
|
Auditory processing disorders with and without central auditory discrimination deficits.
|
J Assoc Res Otolaryngol
|
2014
|
0.77
|
|
59
|
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group.
|
J Clin Oncol
|
2011
|
0.76
|
|
60
|
Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
|
Chin Med J (Engl)
|
2002
|
0.76
|
|
61
|
Speech rehabilitation during the first year after total laryngectomy.
|
Head Neck
|
2012
|
0.76
|
|
62
|
Endoscopic findings of the external ear canal in a group of clinically normal horses and horses with head shaking or vestibular disease.
|
Berl Munch Tierarztl Wochenschr
|
2014
|
0.75
|
|
63
|
Changes in regional energy metabolism after cortical cold lesion in the rat brain.
|
J Mol Neurosci
|
2002
|
0.75
|
|
64
|
Evaluation of the progress of therapy in patients with cleft lip, jaw and palate, using voice analysis--a pilot study.
|
J Orofac Orthop
|
2008
|
0.75
|
|
65
|
[Perceived stigmatisation following laryngectomy].
|
Psychother Psychosom Med Psychol
|
2007
|
0.75
|
|
66
|
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
|
Transfus Apher Sci
|
2007
|
0.75
|
|
67
|
The role of PET in Hodgkin's lymphoma and its impact on radiation oncology.
|
Expert Rev Anticancer Ther
|
2010
|
0.75
|
|
68
|
[Physical fitness in space: measures to prevent muscular atrophy].
|
Sportverletz Sportschaden
|
2002
|
0.75
|
|
69
|
[Focus on academic multicenter trials: impact of the German drug law on hematological/oncological therapy optimization trials].
|
Onkologie
|
2013
|
0.75
|
|
70
|
Motivation as a predictor of speech intelligibility after total laryngectomy.
|
Head Neck
|
2012
|
0.75
|
|
71
|
Brain Integrity Changes underlying Cognitive and Functional Recovery Postliver Transplant Continue to Evolve Over 1 Year.
|
Transplantation
|
2017
|
0.75
|